- Home
- TURN vs FBIO Comparison
TURN vs FBIO Comparison
Compare TURN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- FBIO
- Stock Information
- Founded
- TURN 1981
- FBIO 2006
- Country
- TURN United States
- FBIO United States
- Employees
- TURN N/A
- FBIO N/A
- Industry
- TURN Finance/Investors Services
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- FBIO Health Care
- Exchange
- TURN Nasdaq
- FBIO Nasdaq
- Market Cap
- TURN 39.6M
- FBIO 39.4M
- IPO Year
- TURN N/A
- FBIO N/A
- Fundamental
- Price
- TURN $4.05
- FBIO $1.62
- Analyst Decision
- TURN
- FBIO Strong Buy
- Analyst Count
- TURN 0
- FBIO 3
- Target Price
- TURN N/A
- FBIO $18.00
- AVG Volume (30 Days)
- TURN 41.0K
- FBIO 277.9K
- Earning Date
- TURN 03-04-2025
- FBIO 03-27-2025
- Dividend Yield
- TURN N/A
- FBIO N/A
- EPS Growth
- TURN N/A
- FBIO N/A
- EPS
- TURN N/A
- FBIO N/A
- Revenue
- TURN $194,813.00
- FBIO $81,501,000.00
- Revenue This Year
- TURN N/A
- FBIO N/A
- Revenue Next Year
- TURN N/A
- FBIO $128.63
- P/E Ratio
- TURN N/A
- FBIO N/A
- Revenue Growth
- TURN 254.25
- FBIO 31.51
- 52 Week Low
- TURN $3.12
- FBIO $1.36
- 52 Week High
- TURN $4.47
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- TURN 56.61
- FBIO 33.40
- Support Level
- TURN $3.85
- FBIO $1.65
- Resistance Level
- TURN $4.20
- FBIO $1.85
- Average True Range (ATR)
- TURN 0.14
- FBIO 0.10
- MACD
- TURN -0.00
- FBIO -0.01
- Stochastic Oscillator
- TURN 64.29
- FBIO 7.32
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.